Bill Text: NY S05296 | 2019-2020 | General Assembly | Introduced


Bill Title: Authorizes physicians and pharmacists to enter into comprehensive medication management protocols for their patients.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2020-01-08 - REFERRED TO HEALTH [S05296 Detail]

Download: New_York-2019-S05296-Introduced.html


                STATE OF NEW YORK
        ________________________________________________________________________
                                          5296
                               2019-2020 Regular Sessions
                    IN SENATE
                                     April 23, 2019
                                       ___________
        Introduced  by  Sen. BRESLIN -- read twice and ordered printed, and when
          printed to be committed to the Committee on Health
        AN ACT to amend the public health law and the education law, in relation
          to comprehensive medication management; and to amend chapter 21 of the
          laws of 2011 amending the education law relating to authorizing  phar-
          macists  to  perform collaborative drug therapy management with physi-
          cians in certain settings, in relation to  making  the  provisions  of
          such chapter permanent
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. The public health law is amended by adding  a  new  article
     2  29-H to read as follows:
     3                                ARTICLE 29-H
     4                     COMPREHENSIVE MEDICATION MANAGEMENT
     5  Section 2999-ee. Comprehensive medication management.
     6    §  2999-ee.  Comprehensive  medication  management. 1. Definitions. As
     7  used in this article, the following terms shall have the following mean-
     8  ings:
     9    (a) Qualified pharmacist. The term "qualified pharmacist" shall mean a
    10  pharmacist who maintains a  current  unrestricted  license  pursuant  to
    11  article one hundred thirty-seven of the education law, who has a minimum
    12  of  two  years  of experience in patient care as a practicing pharmacist
    13  within the last five years, and who has demonstrated competency  in  the
    14  medication  management  of  patients with a chronic disease or diseases,
    15  including, but not limited to, the completion of one  or  more  programs
    16  which  are  accredited  by the accreditation council for pharmacy educa-
    17  tion, recognized by the  education  department  and  acceptable  to  the
    18  patient's treating physician.
    19    (b)  Patient  care.  The  term "patient care" shall mean assessing the
    20  appropriateness of prescription and non-prescription drugs for  individ-
    21  ual patients based on an assessment of the patient's medication history,
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00591-01-9

        S. 5296                             2
     1  medication  experience  including  beliefs,  concerns, understanding and
     2  expectations, the clinical  goals  of  therapy,  potential  drug-to-drug
     3  interactions  or  other  medication safety concerns, recommendations for
     4  adherence and consulting with a patient or caregiver.
     5    (c) Comprehensive medication management. The term "comprehensive medi-
     6  cation management" shall mean a program conducted by a qualified pharma-
     7  cist  that  ensures  a  patient's  medications,  whether prescription or
     8  nonprescription, are individually assessed to determine that each  medi-
     9  cation  is appropriate for the patient, effective for the medical condi-
    10  tion, safe given the comorbidities and other  medications  being  taken,
    11  and  able  to be taken by the patient as intended. Comprehensive medica-
    12  tion management conducted by a qualified pharmacist shall include  shar-
    13  ing  of applicable patient clinical information with the treating physi-
    14  cian as specified in a comprehensive medication management protocol.
    15    (d) Comprehensive medication management protocol. The term "comprehen-
    16  sive medication management  protocol"  shall  mean  a  written  document
    17  pursuant  to  and  consistent  with  any  applicable  state  and federal
    18  requirements, that is entered into voluntarily by a  physician  licensed
    19  pursuant  to  article  one hundred thirty-one of the education law and a
    20  qualified pharmacist which addresses a chronic disease  or  diseases  as
    21  determined  by  the treating physician and that describes the nature and
    22  scope  of  the  comprehensive  medication  management  services  to   be
    23  performed by the qualified pharmacist, in accordance with the provisions
    24  of  this article.  Comprehensive medication management protocols between
    25  licensed physicians and qualified pharmacists shall be made available to
    26  the department for review and to ensure compliance  with  this  article,
    27  upon request.
    28    2.  Authorization  to  establish  comprehensive  medication management
    29  protocols. A physician licensed pursuant to article one hundred  thirty-
    30  one  of the education law shall be authorized to voluntarily establish a
    31  comprehensive medication management protocol with a qualified pharmacist
    32  to provide comprehensive medication management services  for  a  patient
    33  who  has  not met clinical goals of therapy, is at risk for hospitaliza-
    34  tion or for whom the physician deems it is necessary to receive  compre-
    35  hensive medication management services.  Participation by the patient in
    36  comprehensive medication management services shall be voluntary.
    37    3.  Scope  of  comprehensive  medication management protocols. Under a
    38  comprehensive medication management  protocol,  a  qualified  pharmacist
    39  shall be permitted to:
    40    (a)  adjust  or  manage  a  drug regimen of a patient, pursuant to the
    41  patient specific order or protocol established by the patient's treating
    42  physician, which may  include  adjusting  drug  strength,  frequency  of
    43  administration  or  route of administration.  Adjusting the drug regimen
    44  shall not include substituting  or  selecting  a  different  drug  which
    45  differs  from that initially prescribed by the patient's treating physi-
    46  cian unless such substitution is expressly  authorized  in  the  written
    47  order  or  protocol. The qualified pharmacist shall be required to imme-
    48  diately document in the patient's medical record  changes  made  to  the
    49  patient's  drug  therapy. The patient's treating physician may prohibit,
    50  by written instruction, any adjustment or change in the  patient's  drug
    51  regimen by the qualified pharmacist;
    52    (b)  evaluate and, only if specifically authorized by the protocol and
    53  only to the extent necessary to discharge the responsibilities set forth
    54  in this article, order disease state laboratory  tests  related  to  the
    55  drug  therapy  management  for  the specific chronic disease or diseases
    56  specified within the written agreement or protocol;

        S. 5296                             3
     1    (c) only if specifically authorized by the written order  or  protocol
     2  and  only  to the extent necessary to discharge the responsibilities set
     3  forth in this article, order or perform routine patient monitoring func-
     4  tions as may be necessary in the drug therapy management, including  the
     5  collecting  and reviewing of patient histories, and ordering or checking
     6  patient vital  signs,  including  pulse,  temperature,  blood  pressure,
     7  weight and respiration; and
     8    (d)  access  the  complete  patient  medical  record maintained by the
     9  treating physician with whom the qualified pharmacist has the comprehen-
    10  sive medication management protocol and document  any  adjustments  made
    11  pursuant to the protocol in the patient's medical record and shall noti-
    12  fy  the  patient's  treating  physician  of  any adjustments in a timely
    13  manner electronically or by other means.
    14    (e) Under no circumstances, shall the qualified pharmacist be  permit-
    15  ted  to  delegate  comprehensive  medication  management services to any
    16  other licensed pharmacist or other pharmacy personnel.
    17    4. Medication adjustments. Any  medication  adjustments  made  by  the
    18  qualified pharmacist pursuant to the comprehensive medication management
    19  protocol  including  adjustments in drug strength, frequency or route of
    20  administration, or initiation of a drug which differs from that initial-
    21  ly prescribed and as documented in the patient's medical record shall be
    22  deemed an oral prescription authorized by  an  agent  of  the  patient's
    23  treating  physician  and  shall  be  dispensed  consistent  with section
    24  sixty-eight hundred ten of the education law. For the purposes  of  this
    25  article,  a  pharmacist  who  is not an employee of the physician may be
    26  authorized to serve as an agent of the physician.
    27    5. Referrals. A physician licensed pursuant  to  article  one  hundred
    28  thirty-one of the education law who has responsibility for the treatment
    29  and care of a patient for a chronic disease or diseases as determined by
    30  the  physician  may  refer  the  patient  to  a qualified pharmacist for
    31  comprehensive medication management services, pursuant to the comprehen-
    32  sive medication management protocol that the physician  has  established
    33  with  the  qualified  pharmacist. The protocol agreement shall authorize
    34  the pharmacist to serve as an agent of the physician as defined  by  the
    35  protocol.  Such  referral  shall  be documented in the patient's medical
    36  record.
    37    6. Patient participation. Participation  in  comprehensive  medication
    38  management  services  shall  be  voluntary, and no patient, physician or
    39  pharmacist shall be required to participate. The referral of  a  patient
    40  for comprehensive medication management services and the patient's right
    41  to choose to not participate shall be disclosed to the patient.  Compre-
    42  hensive  medication management services shall not be utilized unless the
    43  patient or the patient's authorized representative consents, in writing,
    44  to such services. Such consent shall be noted in the  patient's  medical
    45  record.  If  the  patient or the patient's authorized representative who
    46  consented chooses to no longer participate  in  such  services,  at  any
    47  time,  the  services  shall be discontinued and it shall be noted in the
    48  patient's medical record.
    49    § 2. The education law is amended by adding a new  section  6801-b  to
    50  read as follows:
    51    §  6801-b.  Comprehensive  medication  management.  1. As used in this
    52  section:
    53    (a) "comprehensive medication management" shall mean a program for the
    54  management of chronic disease or diseases that ensures a patient's medi-
    55  cations,  whether  prescription  or  nonprescription,  are  individually
    56  assessed  to  determine  that  each  medication  is  appropriate for the

        S. 5296                             4
     1  patient, effective for the medical condition, safe given the  comorbidi-
     2  ties  and  other  medications  being  taken, and able to be taken by the
     3  patient as intended; and
     4    (b)  "comprehensive medication management protocol" shall mean a writ-
     5  ten document, pursuant to and consistent with any  applicable  state  or
     6  federal  requirements,  that  is entered into voluntarily by a physician
     7  licensed pursuant to article one hundred thirty-one of this title and  a
     8  licensed  pharmacist  who meets the qualification requirements specified
     9  in article twenty-nine-H of the public  health  law  which  addresses  a
    10  chronic  disease  or  diseases  as  determined by the physician and that
    11  describes the nature and scope of the comprehensive  medication  manage-
    12  ment  service to be performed by the qualified pharmacist. Comprehensive
    13  medication management protocols between licensed physicians  and  quali-
    14  fied  pharmacists  shall  be made available to the department for review
    15  and to ensure compliance with this article, upon request.
    16    2. A licensed pharmacist qualified pursuant to  article  twenty-nine-H
    17  of  the  public  health  law  is  authorized to serve as an agent of the
    18  physician when executing the terms of the written comprehensive  medica-
    19  tion  management  protocol  as established by the licensed physician for
    20  the management of patients with a chronic disease or diseases.
    21    § 3. Section 5 of chapter 21 of the laws of 2011, amending the  educa-
    22  tion  law  relating  to authorizing pharmacists to perform collaborative
    23  drug therapy management with physicians in certain settings, as  amended
    24  by section 5 of part DD of chapter 57 of the laws of 2018, is amended to
    25  read as follows:
    26    § 5. This act shall take effect on the one hundred twentieth day after
    27  it  shall  have become a law[, provided, however, that the provisions of
    28  sections two, three, and four of this act shall  expire  and  be  deemed
    29  repealed July 1, 2020]; provided, however, that the amendments to subdi-
    30  vision  1  of  section  6801 of the education law made by section one of
    31  this act shall be subject to the expiration and reversion of such subdi-
    32  vision pursuant to section 8 of chapter 563 of the laws  of  2008,  when
    33  upon  such  date  the provisions of section one-a of this act shall take
    34  effect; provided, further, that  effective  immediately,  the  addition,
    35  amendment  and/or  repeal  of  any  rule or regulation necessary for the
    36  implementation of this act on its  effective  date  are  authorized  and
    37  directed to be made and completed on or before such effective date.
    38    §  4.  This  act shall take effect immediately, provided that sections
    39  one and two of this act shall take effect on the one  hundred  eightieth
    40  day  after it shall have become a law.  Effective immediately, the addi-
    41  tion, amendment and/or repeal of any rule or  regulation  necessary  for
    42  the  implementation of this act on its effective date are authorized and
    43  directed to be made and completed on or before such effective date.
feedback